Immunovant Stock Discussion

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...

$SPDR S&P Biotech ETF (XBI.US)$
$Merck & Co (MRK.US)$ x $Immunovant (IMVT.US)$
$Eli Lilly and Co (LLY.US)$ x $Cytokinetics (CYTK.US)$ (and soon)
$Regeneron Pharmaceuticals (REGN.US)$ x $Apellis Pharmaceuticals (APLS.US)$ (panache & brash)
$Gilead Sciences (GILD.US)$ x % $Madrigal Pharmaceuticals (MDGL.US)$ (liver king)
$Bristol-Myers Squibb (BMY.US)$ x $Iovance Biotherapeutics (IOVA.US)$ (cell Tx boost needed)
$Eli Lilly and Co (LLY.US)$ x $Merus (MRUS.US)$ (partner n...

1 | Below is a look at the top insider trades with the biggest value in the past week.
One of $Immunovant (IMVT.US)$'s directors and more than 10% owner, $Roivant Sciences (ROIV.US)$, recently undertook a vast buy transaction worth $58 million. IMVT stock has gained over 104% since the start of this year. It is worth mentioning that Immunovant is a subsidiary of Roivant Sci...

$Immunovant (IMVT.US)$ surged after the company announced positive initial results from both cohorts, the single-ascending dose (SAD) portion and the multiple-ascending dose (MAD) portion of its early-stage study of IMVT-1402.
One of the thing I look out for this stock is its debt in the balance sheet, it only have 10% of its total asset, but question remain whether they would be able to sustain cash burn before they turn profitable or rather when will their cash...

$Immunovant (IMVT.US)$ 🧐

$Immunovant (IMVT.US)$ they added more strike prices!

$Immunovant (IMVT.US)$$32

$Immunovant (IMVT.US)$
850%😯